Hypertension Diagnostics Inc(HDII)
USD --+0.00%
Reward39Moderate
Risk29Low
📊50%Data
Thin -3% profit margin · Revenue down 100% YoY
HDII
+0.0 · +0.00%
USD · PINK
Hypertension Diagnostics Inc | Financial Services
Earnings Deterioration
Market Cap:28478
ℹ️
Reward Rating
39
Moderate
Bottom 5% (model universe)
50% data coverage
ℹ️
Risk Rating
29
Low
Risk Assessment
75% data coverage
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on HDII to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Hypertension Diagnostics Inc?

designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally.

HDII · Verdict

Limited reward · low risk

HDII stands out on balance sheet and volatility, but watch the profitability signal.

Based on 63% data coverage

HDII · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet100/100

    Top decile vs peers

  • Volatility75/100

    Above average

Watchouts 2

  • Profitability10/100

    0% return on equity

  • Valuation32/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Hypertension Diagnostics Inc?

designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 28.48K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (39)

The scoring profile indicates weak reward characteristics across most factors, including growth and momentum. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap28.48K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0002
52 Week Low0.0001
Last AnnualDecember
IPO Date8/7/1998
IncorporatedUSA
Shares OutstandingN/A
No. of EmployeesN/A
IndustryShell Companies
ExchangePINK
Beta-43.384
CurrencyUSD